Hugel wins UAE approval for botulinum toxin Botulax

• The 50IU, 100IU and 200IU formulations screen aesthetic and therapeutic indicatons
• The beardown concern with Medica Group volition boost Hugel's enlargement successful the MENA

, /PRNewswire/ -- Hugel Inc., a starring planetary aesculapian aesthetics institution chaired by Suk Cha, said connected Wednesday it received support for its botulinum toxin Botulax with aesthetic and therapeutic applications from the United Arab Emirates (UAE) connected January 20, achieving a important milestone for the company's planetary expansion.

The support of Botulax successful 50IU, 100IU, and 200IU covers 5 aesthetic and aesculapian indications: eyelid spasm; crow's feet; glabellar lines; precocious extremity musculus spasticity aft stroke; and cerebral palsy adduction deformity successful children.

The institution plans to officially merchandise the toxin Botulax successful the Middle East and North Africa (MENA) astatine the extremity of April. Medica Group, Hugel's aesthetic toxin organisation spouse headquartered successful the UAE with branches successful Saudi Arabia and Lebanon, volition pb the income successful MENA with its beardown determination networks.

Hugel volition accelerate its marketplace enlargement with unsocial income and selling strategies successful the region. Building connected the occurrence of its hyaluronic acerb dermal filler Revolax, which won support successful the UAE successful 2023, the institution volition fortify its broad aesculapian aesthetic portfolios.

The MENA represents 1 of the fastest-growing markets for aesculapian aesthetics, driven by robust economical growth, favorable demographic trends, expanding societal media engagement, and rising request for aesthetic treatments. Hugel is preparing for the support process of its toxin successful different MENA countries specified arsenic Saudi Arabia and Qatar.

"We are excited astir the maturation imaginable successful the MENA marketplace with the support for Botulax with aesthetic and therapeutic indications. Hugel volition grow its concern done the precocious prime of the toxin and Medica Group's broad knowing of the marketplace and its progressive partnerships combined with the determination networks," a Hugel authoritative said.

About Hugel

Established successful 2001, Hugel is simply a planetary person successful aesculapian aesthetics, specializing successful the accumulation of injectables for tegument rejuvenation, including botulinum toxin, hyaluronic acerb fillers, and tegument boosters, arsenic good arsenic absorbable sutures and cosmetic products. As the marketplace person successful injectable aesthetics successful South Korea, Hugel is the lone South Korean institution with regulatory approvals successful the world's 3 largest botulinum toxin markets: the US, China, and Europe. With a proven way grounds of information and quality, Hugel is profoundly committed to advancing the manufacture done robust aesculapian affairs, broad grooming programs, and dynamic manufacture forums. Over the past 20 years, the institution has built a beingness successful astir 70 countries and operates 8 planetary subsidiaries crossed South Korea, the US, Australia, Canada, Taiwan, China, Hong Kong, and Singapore. Leveraging beardown manufacture momentum, Hugel is poised for continued maturation and planetary marketplace expansion.

Contact:
Jihyun Kim, Manager of the PR Team, Hugel
jihyun.kim@hugel-inc.com